Last year, the average increase in premiums at national level was 6%. The figure for 2024 was +8.7%.
Premiums reflect healthcare costs. These costs are continuing to rise, and there is no change in the dynamics at this level,” explained Thomas Christen, deputy director of the Federal Office of Public Health (FOPH), at a press briefing on Tuesday. He cited the ageing population and the cost of new drugs as other causes.
This was expected, but it is nonetheless “worrying”, according to Christen. In the first quarter of 2025, health insurance benefits per person rose by 4.9%, compared with an increase of 4.7% in 2024, according to the latest FOPH figures. This figure could fall further, but it is too early to make any concrete predictions.
The rise in premiums should therefore correspond to the expected increase in costs. “While remaining cautious, we can say that the rise in health premiums in 2026 should be slightly more moderate than in 2025,” explained Philipp Muri, Head of Division at the FOPH.
Reserves
The downward trend in insurers’ reserves observed in recent years was halted in 2024. This should contribute to a more moderate rise in premiums. These reserves are estimated at around CHF7.8 billion for 2024, CHF450 million more than in 2023.
As in previous years, there will be differences between cantons and insurers. What is also decisive is what is expected in terms of healthcare costs for 2026, according to Muri.
Insurers will deliver their forecasts in the summer, at which point the Confederation will be able to take a more precise view. Last week, the Comparis comparison institute forecast a 4% rise in health insurance premiums for next year.
Translated from German by DeepL/mga
How we work
We select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication. Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
Did you find this explanation helpful? Please fill out the short survey below to help us understand your needs.
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
Swiss researchers develop new treatment against lymphoma
This content was published on
The cancer can be effectively combated with the radioactive element terbium. However, the therapy has not yet been tested on humans.
This content was published on
Florian Willet was present when the Sarco suicide capsule was first used in Switzerland in September 2024 and had been placed in pre-trial detention.
This content was published on
At the start of the 113th International Labour Conference in Geneva, Houngbo called for a "more efficient" organisation in front of the 187 member states
Microsoft invests $400 million in Swiss AI expansion
This content was published on
Among other things, the existing data centres in the Geneva and Zurich regions are being expanded as part of this investment.
This content was published on
This is the first study first to report a direct interaction between floating plastic debris in the atmosphere and any species.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.